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Mineral maturity and crystallinity index are distinct
characteristics of bone mineral
Delphine Farlay • Ge´rard Panczer •
Christian Rey • Pierre D. Delmas • Georges Boivin
Abstract The purpose of this study was to test the
hypothesis that mineral maturity and crystallinity index are
two different characteristics of bone mineral. To this end,
Fourier transform infrared microspectroscopy (FTIRM)
was used. To test our hypothesis, synthetic apatites and
human bone samples were used for the validation of the
two parameters using FTIRM. Iliac crest samples from
seven human controls and two with skeletal fluorosis were
analyzed at the bone structural unit (BSU) level by FTIRM
on sections 2–4 lm thick. Mineral maturity and crystal-
linity index were highly correlated in synthetic apatites but
poorly correlated in normal human bone. In skeletal fluo-
rosis, crystallinity index was increased and maturity
decreased, supporting the fact of separate measurement of
these two parameters. Moreover, results obtained in fluo-
rosis suggested that mineral characteristics can be modified
independently of bone remodeling. In conclusion, mineral
maturity and crystallinity index are two different parame-
ters measured separately by FTIRM and offering new
perspectives to assess bone mineral traits in osteoporosis.
Keywords Bone mineral  Hydrated layer  FTIRM 
Mineral maturity  Mineral crystallinity index
Introduction
Human bone mineral is constituted of a poorly crystallized
apatite. It is a calcium (Ca)-deficient apatite, containing
hydrogen phosphate (HPO4), carbonate (CO3), and other
ions. The hydroxyapatite crystal structure belongs to the
hexagonal system. The surface of bone crystal, formed in
the water of extracellular fluid (ECF), exhibits a ‘‘hydrated
layer’’ (Fig. 1). Ions in this layer are very labile and
reactive, and constitute the nonapatitic domain, surround-
ing the relatively inert and more stable apatite domain of
the bone crystal [1, 2]. Newly deposited bone mineral
contains many labile nonapatitic domains [HPO4, phos-
phate (PO4), and CO3], which are located in the well-
developed hydrated layer involved in the high surface
reactivity of mineral [3]. Labile PO4 and CO3 groups are
easily and reversibly exchangeable with each other in the
hydrated layer. During maturation, the decrease in labile
nonapatitic environments is associated with an increase in
stable apatitic environments [3]. A particularity of the bone
mineral is its nonstoichiometry, leading to the presence of
numerous vacancies in the apatite crystal. Consequently,
bone crystal cohesion is mainly maintained by electrostatic
cohesion; thus, bone crystals are easily soluble relative to
stoichiometric apatite [4]. As bone becomes more mature,
both the size and number of crystals increase.
Vibrational spectroscopy techniques, such as Fourier
transform infrared spectroscopy (FTIRS) and synchrotron
infrared or Raman spectroscopy, have been extensively
used to study calcified tissues [3, 5–13]. Spectro-
scopic techniques allow assessment of physicochemical
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modifications of mineral induced by mechanical tests
[5, 14–17], age-related modifications [5, 6, 14, 18], and
pathological or treatment-related changes [7, 19–23]. The
application of Fourier transform infrared microspectros-
copy and imaging (FTIRM, FTIRI) for bone allows in situ
analysis of embedded bone samples at the bone structural
unit (BSU) level.
The purpose of this study was to test the hypothesis that
mineral maturity (transformation of nonapatitic domains
into apatitic ones) and mineral crystallinity index (size/
strain and perfection) are two different characteristics of
bone mineral. These two parameters are temporally linked
and often well correlated in synthetic apatite. However,
they can evolve separately in human bone and thus can
independently affect the mineral characteristics. Indeed,
mineral maturity can be affected by modification of bone
remodeling (and by formative or antiresorptive treatments),
whereas crystallinity can be influenced by ionic substitu-
tions. To test this hypothesis, bone samples from two
patients with skeletal fluorosis were analyzed. Skeletal
fluorosis is a pathology caused by an excessive consump-
tion of fluoride and characterized by ionic substitution of
hydroxyl ions by fluoride ions in bone mineral. Each
parameter was first validated using synthetic apatites and/
or control bone and then measured on seven human sam-
ples from adult controls. Thus, the main purpose of the
present study was to determine, at the BSU level, if we can
distinguish two distinct parameters involved in bone min-
eral characteristics, i.e., mineral maturity and mineral
crystallinity index.
Materials and methods
Synthetic apatites
Six noncarbonated nanocrystalline apatites corresponding
to different maturation periods (0, 1, 3, 15, and 60 days),
and with known HPO4 content (22%, 22.8%, 18.4%, 13%,
and 9.8%, respectively), were prepared as follows: nano-
crystalline biomimetic apatites were prepared by double
decomposition in aqueous media, at physiological pH,
between a solution of calcium nitrate [Ca(NO3)2, 4H2O:
17.7 g for 250 ml deionized water] and an ammonium
hydrogen phosphate solution [NH4)2HPO4: 40 g for
500 ml deionized water]. The calcium solution was poured
rapidly into the phosphate solution. The excess of phos-
phate ions has a buffering effect and allows the pH to
stabilize around 7.4 without the use of any foreign mole-
cules or ions [24]. The suspensions were left to age at room
temperature for variable periods of time (maturation). They
were then filtered on a Bu¨chner funnel and washed with
deionized water until elimination of ammonium and nitrate
counterions. The samples were then freeze-dried and stored
at low temperature (–18C) to prevent any further alter-
ation. The main constituents of the precipitated apatites
were analyzed. The calcium content was determined by
complexometry with ethylenediaminetetraacetic acid
(EDTA), the total phosphate content by UV-vis spectro-
photometry of the phosphovanadomolybdic complex, and
the HPO4
2– fraction using the method proposed by Gee and
Dietz, involving the thermal condensation of hydrogen
phosphate ions into pyrophosphate [25] and the dosage of
pyrophosphate groups. All samples were analyzed by
X-ray diffraction using a curved counter (INEL CP 120, Co
Ka radiation). They presented a pattern characteristic of
poorly crystalline apatites, analogous to those observed for
biological samples (not shown).
Three carbonated apatites (maturation time: 1, 6, and
30 days) containing 3.95%, 5.10%, and 5.69%, respec-
tively, of CO3 were also used [analyses of CO3 were made
by coulometry (Coulometrics CM 5130; UIC Inc.)].
Between 0.7% and 1% of synthetic apatite was mixed
with KBr, compressed into pellets, and then analyzed by
FTIR macrospectroscopy.
Human bone samples
Seven iliac crest bone samples from adult controls (43–
93 years old) without apparent metabolic bone disease
were obtained at necropsy (Universite´ Claude Bernard,
Lyon, France). Iliac crest bone samples from two patients
with skeletal fluorosis were also analyzed. Skeletal fluo-
rosis was diagnosed on clinical, radiologic, and histomor-
phometric criteria and confirmed using a chemical dosage
Fig. 1 Evolution of the hydrated layer and crystal apatite. During the
maturation and growth of the crystal, the hydrated layer, involved in a
high surface reactivity, progressively decreased and led to a stable
apatitic domain. The structure of the hydrated layer constitutes a pool
of loosely bound ions that can be incorporated in the growing apatite
domains and can be exchanged by foreign ions in the solution and
charged groups of proteins (Pr). Courtesy of C. Rey (Rey et al.
(2009), Osteoporos. Int 20:1013–1021)
of fluoride with a specific ion electrode. Bone samples were
fixed in alcohol, dehydrated in absolute alcohol, and then
embedded in methylmethacrylate (MMA). Nondecalcified
sections (2–5 lm thick) were cut with a microtome Polycut
E [Reichert-Jung (Leica), Germany].
FTIR spectroscopy and microspectroscopy
For FTIR spectroscopy performed on KBr pellets, a dried-
air purge system was used to minimize air and CO2 bands.
For each pellet, 20 scans were collected at 4 cm–1 resolu-
tion in the transmission mode and analyzed with a Fourier
transform infrared microspectroscope (PerkinElmer GXII
Auto-image Microscope) equipped with a wideband
detector (mercury–cadmium–telluride) (7800–400 cm–1).
After baseline correction by automatic correction and
normalization at absorbance 1.5 on the m3PO4 (Spectrum
Software), the curve-fitting of every individual spectrum
was performed.
Fourier transform infrared microspectroscopy was per-
formed on sections 2–5 lm thick. Each spectrum was
collected at 4 cm–1 resolution and 200 scans in the trans-
mission mode. The instrument used an objective Casse-
grain of numerical aperture 0.6; the system has a spatial
resolution of 10 lm at typical midinfrared wavelengths.
Contributions of air and MMA were subtracted from the
original spectrum. Each spectrum was baseline corrected
and normalized at absorbance 1.5 on the m3PO4. For the
seven control human bone samples, spectra of 5–10 areas
of 50 9 50 lm were acquired separately in newly formed
and old interstitial bone, in both cortical and cancellous
bone, with a total of 20–40 measurements for each sample.
Selection of newly formed and old bone was based on
morphological criteria. The new bone is the surface bone
and the old is the interstitial bone. Because a great part of
the old bone is quiescent in the surface, the new bone is
differentiated according to its low mineralization index. In
patients with double tetracycline labeling, the sections
were observed under fluorescent light to identify newly
formed bone.
GRAMS/AI software (Thermo Galactic, Salem, NH,
USA) was used to quantify the characteristics of the
spectra. For the phosphate vibration, we used synthetic
hydroxyapatites, carbonated apatites, and previously pub-
lished data [13]. Concerning m1m3PO4 vibration, five sub-
bands were used (1110, 1082, 1060, 1030, and 962 cm–1),
and for the m4PO4 vibration, four subbands were used (604,
577, 563, and 552 cm–1). After curve-fitting of every
individual spectrum, position, height, full width at half-
maximum (FWHM), and area under the curves were
measured. Peaks corresponding to m1m3PO4 (900–
1200 cm–1) and m4PO4 (500–650 cm
–1) were analyzed. The
following parameters were calculated: (1) mineral maturity
(1030/1110 cm–1 area ratio); (2) mineral crystallinity index
(defined as being inversely proportional to the FWHM of
604 cm–1 peak). The peak located at 604 cm–1 is of par-
ticular interest because of its good resolution. It corre-
sponds to the apatitic phosphate environment and gives
direct information on the crystallinity index of the sample.
The narrower the peak is, the higher the crystallinity index.
To validate the width at half-height of 604 cm–1 as a
crystallinity index by infrared spectroscopy, this latter has
been compared on the same samples with the crystallinity
index measured by the Shemesh method [26], derived from
the splitting factor measured by Termine and Posner [27].
This crystallinity index [28] corresponds to the splitting of
a triply degenerate antisymmetrical bending vibration of
orthophosphate and to the following ratio: CI = (A604 ?
A564)/A590, where Ax is the absorbance at wavenumber x
(Fig. 2a).
X-ray diffraction (XRD)
X-ray diffraction, used to validate the measurements of
crystallinity performed by FTIRM, was done at the Centre
de Diffractome´trie Henri Longchambon (Universite´ de
Lyon, France). Powdered synthetic samples were analyzed
using a Bruker D8 Advance diffractometer equipped with
a PSD Detector (VA˚NTEC-1 ‘‘Super Speed’’). Profiles
were obtained between 0 and 70 2h, and a count of 2 s
Fig. 2 Synthetic apatites, m4PO4 vibration. a Crystallinity index (CI)
measured by Shemesh’s method [26], given by CI = {A604 ? A564}/
A590. b Correlation between the CI measured by Shemesh’s method
and by Fourier transform infrared microspectroscopy (FTIRM) in
which CI is inversely proportional to the full width at half-maximum
(FWHM) of the 604 cm–1 peak
was performed at room temperature every 0.2. Two dif-
ferent crystallographic directions were analyzed: the 002
and 310 reflections. The 002 reflection was related to the
length axis (c-axis), and 310 reflection was related to the
dimension perpendicularly to the c-axis (crystal width).
For bone samples, thick sections of bone biopsies were
analyzed by XRD. Two pairs of measurement were done,
with one fluorotic bone and one control bone, age- and sex-
matched for each pair. XRD analyses were performed
between 20 and 45 2h, with a timescale of 40 (equivalent
to a measurement on a scintillation counter with a step of
2/100 and an exposure time of 40 s/step). The FWHM of
002 and 310 reflections were analyzed after curve-fitting
with TOPAS P software (Bruker). The narrower the peak,
the higher is the crystallinity.
Statistical analysis
Nonparametric tests were used because of the small num-
ber of samples. Four regions of interest were studied: new
and old cortical bone, and new and old cancellous bone.
Data were analyzed using two-way analysis of variance
[Friedman analysis of variance (ANOVA)]. If differences
were significant, Wilcoxon’s t test was used to compare
either cortical versus cancellous or new versus old bone.
Spearman correlations between methods and between
parameters were performed. A test is considered significant
if P B 0.05.
Results
Validation of the characteristics of mineral
A part of a spectrum obtained from a synthetic apatite in
the region corresponding to PO4 and CO3 vibrations is
illustrated in Fig. 3.
Mineral maturity
Mineral maturity represents the progressive transformation
of nonapatitic domains into poorly crystallized then well-
crystallized apatite (see Fig. 1). This parameter is mea-
sured as the evolution of the m1m3PO4 vibration in synthetic
apatites of known state of maturation (Fig. 4a). The vari-
ation of the content of HPO4 ions essentially located in the
hydrated layer reflects its evolution. The 1030 cm–1 peak
has been assigned to apatitic phosphate groups and is
observed in well-crystallized stoichiometric hydroxyapatite
[13]. The 1110 cm–1 peak is present in nanocrystalline
apatites, and it has been assigned to nonapatitic phosphate
or HPO4 in poorly crystalline apatite [13, 29, 30]. Thus, the
area ratio 1030/1110 cm–1 gives an index of mineral
maturity corresponding to the transformation of a nona-
patitic domain into apatitic ones. In synthetic apatites, this
area ratio increases progressively with mineral maturation
(Fig. 4b) and is inversely correlated with the HPO4 content
(r2 = 0.89, P \ 0.02).
Mineral crystallinity index
Mineral crystallinity is defined as the degree of order in a
solid as measured by XRD. Validation of the crystallinity
index values was done first by comparing measurements
done by FTIRM (inversely proportional to the FWHM of
the 604 cm–1 peak assigned to phosphate ions in the apatite
domains) and the ratio used by Shemesh et al. [26]. Results
have shown that there is an excellent correlation between
the two crystallinity indexes measured by FTIR (see
Fig. 2b; r0 = 0.96, P = 0.011). Then, our crystallinity
index (inversely proportional to the FWHM of the
604 cm–1 peak) has been compared with measurements
done by XRD (FWHM of 002 and 310 apatite reflections).
A good and significant correlation was found (r0 = 0.93,
P = 0.0083; r0 = 0.91, P = 0.016, respectively) in syn-
thetic apatites between the crystallinity parameters mea-
sured by FTIRM and by XRD (Fig. 5a, b).
Correlation between mineral maturity and crystallinity
index in synthetic apatites
In synthetic apatites (Fig. 5c), mineral maturity and crys-
tallinity index were highly correlated (r0 = 0.92, P \ 0.02)
and thus temporally linked.
Bone mineral from human controls
The spectra obtained from new and old bone in human
adult controls (see Fig. 3) illustrated differences in mineral
Fig. 3 Infrared spectra obtained from (I) a synthetic carbonated
apatite and showing the m1m3PO4, m2CO3, and the m4PO4 vibrations
(bold curve), (II) new (full curve), and old (dotted curve) bone
showing different vibrations, including those of amides (I, II, and III)
associated with the aging of bone. For all four bone areas,
differences were significant (P = 0.0014–0.0056). Com-
parisons between cortical versus cancellous or new versus
old bone are shown in Table 1.
Mineral maturity
The 1110 cm–1 peak was less intense in old interstitial bone
than in newly formed bone (young BSUs) (Fig. 6a, b).
The area ratio 1030/1110 cm–1 was always higher in old
interstitial bone than in newly formed bone. A significant
difference (P \ 0.03) was found between cortical and
cancellous bone in old bone (Table 1).
Mineral crystallinity index
In human controls, the crystallinity index was found to be
higher in old interstitial bone than in newly formed bone
(FWHM = 24.536 in old bone vs. 25.078 in new bone;
crystallinity index is higher when FWHM is weak). No
significant differences were observed between cortical and
cancellous bone (see Table 1).
Correlation between mineral maturity and crystallinity
index in human controls
There was a significant but weak correlation (r0 = 0.38)
between mineral maturity and crystallinity index (see
Fig. 5d). In human controls, compared with synthetic ap-
atites, the decrease of correlation between mineral maturity
and crystallinity index seems mainly caused by the pres-
ence of a larger amount of nonapatitic domain in human
bone than in synthetic apatites. Moreover, it is important to
mention that there is a significant difference between cor-
tical and cancellous old bone in mineral maturity but not in
crystallinity index.
Observations in skeletal fluorosis
In the two cases analyzed, mineral maturity and crystal-
linity index showed different patterns. Compared with
Fig. 4 Evolution of mineral
maturity (m1m3PO4) vibration in
various synthetic apatites.
a Nonapatitic phosphates
(1110 cm–1) decreases with the
progression of mineral
maturation whereas the apatitic
phosphates (1030 cm–1) are
constant. b Mineral maturity
increases with the progression
of maturation (d, days of
maturation)
human controls, mineral crystallinity index was higher and
mineral maturity was slightly lower in the fluorosis sam-
ples (Table 1).
XRD analysis performed on two pairs of bone sam-
ples (fluorotic and normal bone) revealed that the fluo-
rotic bone present overall a higher crystallinity. Analyses
of 002 and 310 reflections showed that the 310-line
width was highly decreased in fluorosis compared with
normal bone, while 002 reflection was unchanged.
FTIRM analysis of the same samples showed that
FWHM of 604 cm–1 peak is decreased as well in fluo-
rosis compared with normal bone (in cancellous old
bone, FWHM = 19.131 in fluorotic bone vs. 24.636 in
control bone; Fig. 7).
Correlation between mineral maturity and crystallinity
index in skeletal fluorosis
No correlation was found between mineral maturity and
crystallinity index. Mineral maturity is lower and mineral
crystallinity index is higher in fluorotic bone compared
with control bone.
Discussion
The main purpose of the present study was to test the
hypothesis that, at the BSU level, two distinct parameters
were involved in bone mineral quality, i.e., mineral
maturity and mineral crystallinity index. Although those
two parameters often evolve concomitantly, it is current
use to speak about mineral maturity/crystallinity and to
combine the two parameters into one. By definition, they
are not equivalent and correspond to two different entities.
Maturity is related to the ratio of apatitic and nonapatitic
domains, whereas crystallinity depends on both the per-
fection of the apatite crystalline domains and their size/
strain. We have shown on normal and pathological bone
(fluorotic bone) that the two parameters, mineral maturity
and mineral crystallinity index, had to be considered sep-
arately. Several attempts have been made to determine
mineral maturity and crystallinity index by infrared spec-
troscopy [10, 11, 26, 27, 31]. Mineral maturity and crys-
tallinity index are often not separated and they are
expressed as a single parameter [32, 33]. Several terms
have been used to describe bone mineral: crystallinity,
Fig. 5 Evolution of mineral crystallinity and correlation between
crystallinity index and mineral maturity in synthetic apatites.
a Significant correlation between the crystallinity index measured
by FTIRM (604 cm–1 peak) and the crystallinity measured by X-ray
diffraction [XRD, 002 reflection]. b Significant correlation between
the crystallinity index measured by FTIRM (inversely proportional to
the FWHM of 604 cm–1 peak) and the crystallinity measured by the
XRD 310 reflection. c Correlation between mineral maturity and
mineral crystallinity index in synthetic apatites. These two parameters
are closely linked (FWHM, full width at half-maximum). d Corre-
lation between mineral maturity and mineral crystallinity index in
human bone
maturity, crystal size, crystalline perfection. However, the
association of these physicochemical parameters with the
characteristics of the crystals, i.e., shape, length, width, and
ordering of ions, has remained difficult and has sometimes
been controversial. During the formation of bone mineral
crystals, two main characteristics are noted, reflecting bone
mineral characteristics: first, mineral maturity, which cor-
responds to the progressive transformation of immature
surface-hydrated domains into a mature and more stable
apatite lattice; and second, mineral crystallinity index,
which corresponds to the size and strains of these apatite
domains [34]. It appears essential to separate mineral
maturity and crystallinity index, because they do not rep-
resent the same mineral characteristics. Our results
obtained in human fluorotic bones have required their
separation because they corresponded to different mineral
entities.
Infrared spectroscopy is a technique providing infor-
mation especially about covalent bonds of molecules.
Chemical groups (e.g., hydroxyl, phosphate, amide) can be
identified by their specific absorption at different wave-
numbers. In all the spectroscopic techniques [nuclear
magnetic resonance (NMR), Raman, infrared spectros-
copy], a modification in the size and strain of crystalline
Table 1 Mineral maturity and mineral crystallinity index measured in iliac bone samples from human adult controls and from patients with
skeletal fluorosis
Mineral maturity
(area ratio, 1030/1110 cm–1),
mean (SD)
Mineral crystallinity index
(inversely proportional
to FWHM, 604 cm–1),
mean (SD)
Control bone (n = 7)
Total new bone 1.643 (0.265) 25.078 (0.923)
Total old bone 1.926a (0.274) 24.536b (0.641)
Cortical new boned 1.738 (0.280) 25.166 (0.693)
Cancellous new boned 1.549 (0.230) 24.990 (0.994)
Cortical old boned 2.046 (0.271) 24.636 (0.693)
Cancellous old boned 1.806c (0.236) 24.436 (0.994)
Fluorotic bone (n = 2)e
Cortical new bone 1.293 (0.056) 20.377 (1.711)
Cancellous new bone 1.185 (0.078) 20.170 (0.670)
Cortical old bone 1.534 (0.187) 19.062 (1.302)
Cancellous old bone 1.422 (0.047) 19.131 (0.868)
FWHM full width at half maximum, NS not significant, SD standard deviation
a Wilcoxon’s t test: comparison of new bone versus old bone, P = 0.001
b Wilcoxon’s t test: comparison of new bone versus old bone, P \ 0.006
c Wilcoxon’s t test: comparison of cortical old versus cancellous old bone, P \ 0.03
d Mean of 5–10 measurements per sample in each compartment : Friedman ANOVA, P = 0.0014–0.0056
e For each sample, mean of 5–10 measurements per sample in each compartment
Wilcoxon’s t test: comparison of cortical new versus cancellous new bone, NS
Fig. 6 In human bone and at
the level of the m1–m3PO4
vibration, the 1110 cm–1 peak
(nonapatitic domain) is less
intense in old bone (a) than in
new bone (b). This result
reflects that mineral maturation
of old interstitial bone is greater
than that of newly formed bone
domains involves a broadening and sometimes a distortion
of lines, observed on the spectra. It is thus possible to
determine a crystallinity index with this technique, as in
Raman spectroscopy. Ionic substitutions occurring within
apatite domains especially influence the environment of
vibrating units and result in broadening of the specific lines
related to these crystalline domains. In contrast, substitu-
tions in the hydrated layer have little or no influence on the
crystalline apatite lattice. Consequently, infrared spectros-
copy is sensitive to both the chemical environment of
molecules, allowing the distinction of surface hydrated
layer and crystalline apatite domains, and, when focusing
on specific apatite lines, the crystallinity of these domains.
During mineral maturation, the hydrated layer decreases
while the stable apatite domains grow, corresponding to the
evolution of nonapatitic environments of mineral ions into
apatitic environments detected by FTIR. This hydrated
layer, different from a hydration layer (Stern double layer),
corresponds to the mode of formation of apatite crystals in
physiological conditions. The existence of these two
domains, a hydrated layer and an apatite core in biomi-
metic nanocrystals, has been recently confirmed by solid-
state NMR [35]. The hydrated surface layer contains
loosely bound ions, which are easily exchangeable and
determine the surface properties of the nanocrystalline
apatites [1, 3]. In bone, those loosely bound ions can be
also exchanged with charged groups of proteins present in
collagen and noncollagenous proteins. Several studies have
shown the role of charged proteins on mineralization [36–
38]. Recently, Dziak and Akkus have shown that some
polyelectrolytic peptides could affect the quality of mineral
crystals in vitro [39]. In infrared spectroscopy, the m1m3PO4
domain presents intense bands generated by phosphate
ions, the most intense being the 1030 cm–1 peak, which has
Fig. 7 Example of one pair of samples analyzed by X-ray diffraction
(XRD) (fluorotic bone, red; control bone, black) and by FTIRM. XRD
diagram shows the decrease of the full width at half-maximum
(FWHM) (2h) of the 310 reflection in fluorosis, while 002 reflection
is unchanged. Regarding the overall aspect of XRD diagram of the
two samples, fluorotic bone is more crystallized than control bone.
FTIRM analysis shows a decrease of the FWHM of the 604 cm–1
(peak-fitting inserted) of the fluorotic bone, indicating an increase in
mineral crystallinity index
been assigned to one component of the triply degenerated
m3PO4 antisymmetrical stretching, vibrational mode of the
PO4 groups in stoichiometric apatite [13]. The 1020 cm
–1
line has been associated with nonstoichiometric, poorly
crystalline apatite and is present at the early stage of
mineralization [13]. Those two peaks have been first
identified by Rey et al. with the technique of Fourier self-
deconvolution [13]. Later, Boskey’s group used the ratio of
different peaks in this domain (among 11 peaks) based on
second derivative treatment of the spectra of bone [10].
However, in our opinion, the use of a curve-fitting process
involving 11 underlying bands to fit the m1m3PO4 vibration
does not appear reproducible and stable enough, and may
lead to different solutions, even if numerous bands improve
the criteria of convergence between the computed and the
raw spectra. In addition, the assignment and meaning of all
these bands is far from being completed. In earlier studies,
Pleshko et al. used a maximum of six underlying compo-
nents with the same technique of curve-fitting [11]. Later,
Boskey et al. used the correlations established between
FTIR and the XRD analyses on synthetic and biological
samples to establish an index mineral maturity/crystallin-
ity, using the 1030/1020 area ratio [10]. This ratio has
become a standard largely used in the literature, especially
by this group. This ratio increases with the maturation and
the crystal size in synthetic samples or normal biological
samples, and we agree with this observation. However,
according to our interpretations, the 1030/1020 area ratio
corresponds to the ratio of apatitic over nonapatitic phos-
phate and therefore to a mineral maturity index rather than
a crystallinity index. The good correlation between FTIR
maturity index and the crystallinity provided by XRD does
not mean that these two parameters measure the same
characteristics of the mineral, but simply means that these
characteristics evolve concomitantly in the samples ana-
lyzed. It would be erroneous to believe that an increase in
the 1030/1020 ratio is necessarily always related to an
increase of crystal size. An increase of the 1030/1020 ratio
means that there is an increase of the mineral maturity, i.e.,
a more important proportion of apatitic domain compared
with nonapatitic surface domain, meaning the bone is
older. However, it does not mean that the crystal size has
necessarily increased, as it has been suggested in some
studies [7]. This suggestion is based on the assumption that
these parameters are always linked by the same phenom-
enological correlation, which cannot be ascertained for all
bone mineral formation, even if we recognize that some-
times the maturation and crystallinity are correlated. For
example, if bone mineral contains a substance modifying
the crystallinity (for example, by an antiosteoporotic
treatment or a pathology), the mineral maturity can be
normal but the crystallinity index is increased, simply
because of its presence in bone mineral. It does not suggest
that the crystals are larger or more mature. From there on,
there has been much confusion between the two charac-
teristics: mineral maturity and crystallinity index. In our
experiments, the 1030/1110 area ratio was chosen because
the 1020 cm–1 line is not clearly resolved on raw spectra
and thus is not identifiable compared with the 1110 cm–1
line. Exactly like 1020 cm–1, the 1110 cm–1 peak is present
in freshly precipitated apatite and is assigned to the m3PO4
antisymmetrical stretch or HPO4 stretch in poorly crystal-
line apatite [13, 29, 30]. It disappeared progressively dur-
ing maturation in biological and synthetic samples [40].
During the conversion of amorphous calcium phosphate
into hydroxyapatite, four peaks (1020, 1038, 1112, and
1127 cm–1) can be attributable to nonstoichiometry or the
presence of acid phosphate-containing species [30]. In
young bone mineral, the 1110 cm–1 peak is predominant
[13] and better resolved compared with the 1020 cm–1
peak. Our results show that the 1110 cm–1 peak is less
intense in synthetic apatites than in newly formed BSUs.
However, in both synthetic apatites and human bone, the
ratio 1030/1110 increased with mineral maturation.
Moreover, invariably in human adult controls, old inter-
stitial bone was significantly more mature than newly
formed bone. For this reason, we have chosen the
1110 cm–1 rather the 1020 cm–1 peak. We have also per-
formed, on bone control samples, the correlation between
the 1030/1020 cm–1 and the 1030/1110 cm–1 ratio, using
the intensity of raw spectra and not the area ratio (peak
curve-fitting; it is important to emphasize once more that
the 1020 cm–1 was not clearly identifiable on spectra). The
two ratios are significantly correlated, and thus they show a
similar evolution (r0 = 0.86, P \ 0.0001).
An important characteristic of bone mineral is its ability
to accept ionic substitutions and vacancies; this can affect
several parameters such as crystallinity of the apatite
domains, physicochemical functions, morphology, and
crystal size. m4PO4 vibration has been extensively used to
analyze the crystallinity index of the apatite domains in
vibrational macroscopic spectroscopy [9, 12, 40, 41], but is
often inaccessible for microscopic infrared study, particu-
larly in FTIRI (because of the limit of detection of the
cutoff of the detector used in a conventional IR micro-
scope). The use of a wide-band detector allowed access to
this part of the infrared spectrum. Crystallinity of the
apatite domains can be assessed by several methods [XRD,
wide-angle X-ray scattering (WAXS), small-angle X-ray
scattering (SAXS), vibrational spectroscopy (FTIR and
Raman), NMR spectroscopy] [42]. Several parameters
have been used to assess crystallinity index by infrared
spectroscopy methods on m1m3PO4 [11] or m4PO4 [9, 27].
Several indicators of mineral crystallinity have been pro-
posed. Termine and Posner first used the resolution ratio of
the m4PO4 band, i.e., the splitting factor [27]. Several
studies have used similar ratios to describe crystallinity
[26, 41]. Bands in the m4PO4 arise from the antisymmetrical
P–O bending modes of the phosphate groups. The FWHM
of the m1PO4 line has been commonly used in Raman
spectroscopy to represent the apatite crystallinity [43–45].
Increasing crystallinity indicates that a greater proportion
of crystals have larger size and/or a stoichiometrically
more perfect lattice with fewer substitutions [39]. How-
ever, infrared spectroscopy is not able to dissociate the
influence of crystallite size from the lattice imperfections.
We have chosen to analyze m4PO4 to measure the crystal-
linity index because it presented well-resolved peaks
assigned with certitude to apatite lattice, and it has already
been proposed to serve as an IR crystallinity index [9, 26,
27]. Among the different possibilities, we chose the well-
resolved 604 cm–1 line. To confirm the robustness of using
the FWHM of the 604 cm–1 line (inversely proportional to
crystallinity index; the narrower the peak is, the higher the
crystallinity index), we have compared, on the same sam-
ples, the results obtained with the measurement of another
crystallinity index published by Shemesh [26], which is a
derived ratio of the splitting factor used by Termine and
Posner [27]. There is an excellent and significant correla-
tion between the two crystallinity indexes measured dif-
ferently on the same phosphate vibration. Therefore, the
use of the FWHM, as in the way it is often used in Raman
spectroscopy, gives a very good indication of the state of
crystallinity of the sample. We chose the crystallinity index
of the apatite domains based only on FWHM of the
604 cm–1 line (inversely correlated to crystallinity index),
clearly assigned to apatite phosphate groups. This crystal-
linity index seems more reliable than the resolution factors
proposed by different authors, which may depend also on
the position variations of the two main apatite phosphate
peaks and on the possible presence of underlying non-ap-
atitic phosphate absorption bands. Our results on the
604 cm–1 peak showed that in the mineral of newly formed
bone, apatite domains are invariably less well crystallized
than in old interstitial bone. This involves a better orga-
nization of mineral ions in the apatite lattice in old bone
than in newly formed bone. A low crystallinity can be due
to the fact that the apatite domains are small and poorly
organized in nascent crystals of young bone, but it could
also occur as the result of the accelerated remodeling.
Another peak (563 cm–1) in the m4PO4 vibration, not
described in this study, is also interesting because it
probably contains a contribution of nonapatitic domains
[9, 12].
The strong correlation between mineral maturity and
crystallinity index in synthetic apatites suggests that these
two parameters are temporally linked, and this is in
agreement with previous results showing that the area ratio
of 1030/1020 cm–1 lines (apatitic PO4/nonapatitic PO4) is
well correlated with the crystallinity measured by XRD
[31, 33]. Our results are in agreement with those results,
showing that mineral maturity evolves generally in parallel
with crystallinity index in a normal bone. However, the
chemistry and development of biological apatite is very
different compared with synthetically grown apatite. Min-
eral maturity represents a stage of maturation, whereas
crystallinity is involved in the organization of the apatite
lattice. Thus, in physiological conditions, it makes sense
that mineral maturity and crystallinity index evolve simi-
larly, i.e., that when apatitic environments become more
important than nonapatitic environments, apatite domains
have grown and have become more perfect. In controls,
mineral maturity in old bone was significantly higher in
cortical than in cancellous bone, but crystallinity index was
not, which suggests that the two parameters evolve dif-
ferently. A recent study performed in our laboratory by
Bala et al. [46] shows that in ewes (an animal model with a
remodeling activity close to humans) the kinetics of evo-
lution of the two parameters is different. Mineral maturity
is more rapidly completed than crystallinity index, which
could suggest that mineral maturity occurs rapidly to reach
a certain stability of the crystal, and when this is attained,
there is a progressive increase in the crystallinity index
with a slow increase in size. This observation reinforces the
fact that it is important to separate mineral maturity from
crystallinity index. However, it is possible to have a dis-
ruption of these parallel evolutions, in certain conditions,
for example, when an ionic substitution occurs in apatite
lattice. In a case of ionic substitution introducing distor-
tions in the apatite lattice, crystallinity index is modified.
However, maturity linked to the dynamic of bone remod-
eling is different from the static effect linked to the state
of the mineral, i.e., crystallinity (size/perfection). It is
important to emphasize that the correlation between the
two parameters with X-ray methods has led to the
simultaneous expression of maturity/crystallinity. To verify
the hypothesis that incorporation in the apatite lattice of
foreign ions could produce a change in crystallinity index
without modifications of mineral maturity, these two
parameters were measured in samples from patients
with skeletal fluorosis. In the latter, the crystallinity
index is increased, because of the substitution of OH–
by F– ions, which are easily incorporated into the apatite
lattice by means of their small ionic radius
ðrF ¼ 1:33 A˚; rOH ¼ 1:45 A˚), producing a smaller unit
cell volume [47]. This finding is in agreement with other
studies showing that the increase in crystallinity was rela-
ted to the F– content in shark dentine [8], in enamel [28],
and in bone mineral [48–50]. However, mineral maturity is
slightly decreased. This decrease indicates the presence of
young mineral deposition resulting from the stimulation of
osteoblastic activity, enhanced by fluoride [51]. Thus, in
spite of the fact that the great order of ions in the apatite
lattice in skeletal fluorosis explains the increase in crys-
tallinity index, the mineral maturity is decreased. Although
mineral maturity and crystallinity index were not distin-
guished previously [7, 10, 32, 33, 52], those results
emphasize for the first time that the two parameters must be
measured separately.
Separate measurements of mineral maturity and crys-
tallinity index by FTIRM suggested different implications
of these parameters in bone strength. Bone mineral crystals
are extremely small, inducing a large specific surface of
bone crystals, and contributing to an increased quantity of
electrostatic bonds between mineral and collagen matrix.
Mechanically, the highly ordered location and orientation
of very small crystals within the collagen fibrils not only
contribute to the rigidity and strength of the bone sub-
stance, but their small size also permits an acceptable range
of flexibility without fracture or disruption of the bone
substance [34, 53]. In fluorosis, bone is very fragile [54–
57]. A negative correlation was found between crystal
width and fracture stress of femur in rabbits and rats treated
with fluoride [55]. The high crystallinity index in fluorosis
suggested organization of the crystals, and an increase of
the size of the crystals. However, the presence of large
crystals decreases the surface area with collagen fibrils and,
therefore, does not contribute to mechanical strength [54,
58]. Thus, the bone fragility observed with fluoride, and the
modifications in bone mineral shown in the present study in
fluorosis, suggest that mineral crystallinity index and
mineral maturity could independently influence bone
strength. Recently, the importance of mineral crystallinity,
investigated by Raman spectroscopy, on mechanical
properties of human bone has been demonstrated. Crys-
tallinity alone explains 7–48% of the variation on mono-
tonic mechanical properties and also 11–63% of the
variation of the fatigue properties [59]. It must be also
mentioned that the crystal orientation plays an important
role in biomechanical properties [20, 60]. A recent study on
slices of bovine femur has shown, by XRD analysis, that
the deformation of crystals induced by tensile loading was
different according to their degree of orientation, and the
deformation behavior of mineral crystals depended on
structural anisotropy [61].
Antiosteoporotic treatments act either by a stimulation
of bone formation (teriparatide) or by a decrease of bone
resorption (bisphosphonates), or by both mechanisms.
Consequently, these treatments can influence mineral
maturity, with a lowest mineral maturity with anabolic
treatments, and conversely a highest mineral maturity with
antiresorptive treatments. It has been shown that 3 and
5 years of treatment with risedronate preserved the mineral
maturity/crystallinity, whereas after 3 years of placebo,
there were significant changes (continued maturation) in
the bone matrix, suggesting that risedronate arrested the
tissue aging encountered in osteoporosis [62]. Crystallinity
can also be influenced by the mineralization rate, and this
has been shown in osteoporosis where the increase in bone
remodeling increased the mineral maturity/crystallinity
parameter [32]. These data underscore the simultaneous
measurement of several parameters involved in bone
mineral traits for a better understanding of the mechanisms
of action of the various treatments of osteoporosis.
Three main limitations appeared in our study. First, it
should be emphasized that this study analyzes intrinsic
characteristics of bone mineral, and not the remodeling
activity. Thus, measurements did not take into account the
relative amount of bone, but were done at the BSU level as
a function of the age of bone. Second, infrared spectros-
copy was aimed at the midrange order compared with
XRD, which gave long-range order information and
directly addressed the distances and regularity of the
arrangements of atoms/molecules in a crystal lattice. Thus,
infrared spectroscopy was less sensitive to modification of
the long-range order whereas XRD allowed it. Third, the
small number of samples reduced the ability to detect
differences with age, as shown by Hanschin and Stern [63].
They showed by XRD that the most important variations
appeared within the first 30 years, with a distinct reduction
in the peak width of the 002 and 310 reflections.
In conclusion, we have demonstrated that mineral
maturity and crystallinity index are two different parame-
ters that do not refer to the same domain of crystals. These
two parameters need to be distinguished in later studies on
bone mineral. They will then be used to analyze modifi-
cations of bone quality at the crystal level in bone samples
from osteoporotic patients treated, or not treated, for a
better understanding of the mechanisms of bone fragility.
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